Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics by Hofvind, S, Holen, Å, Aas, T, Roman, M, Sebuødegård, S, Akslen, L.A

Get full text

Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer by Krüger, K, Stefansson, I.M, Collett, K, Arnes, J.B, Aas, T, Akslen, L.A

Get full text

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial–mesenchymal transition and PI3K alterations by Wik, E, Trovik, J, Kusonmano, K, Birkeland, E, Raeder, M.B, Pashtan, I, Hoivik, E.A, Krakstad, C, Werner, H.M.J, Holst, F, Mjøs, S, Halle, M.K, Mannelqvist, M, Mauland, K.K, Oyan, A.M, Stefansson, I.M, Petersen, K, Simon, R, Cherniack, A.D, Meyerson, M, Kalland, K.H, Akslen, L.A, Salvesen, H.B

Get full text

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients by Engstrøm, M. J., Opdahl, S., Hagen, A. I., Romundstad, P. R., Akslen, L. A., Haugen, O. A., Vatten, L. J., Bofin, A. M.

Get full text

Safety and efficacy of dendritic cell (DC)-based cryoimmunotherapy (CryoIT) combined with checkpoint inhibition in a prospective non-randomized Phase I trial of metastatic castrati... by Thomsen, L.C.V., Honoré, A., Almås, B., Reisæter, L.A.R., Førde, K., Kristoffersen, E.K., Kaada, S.H., Melve, G.K., Helle, S.I., Kvalheim, G., Azeem, W., Olsen, J.R., Halvorsen, O.J., Akslen, L.A., Bahn, D., Pantel, K., Riethdorf, S., Ragde, H., Gjertsen, B.T., Øyan, A.M., Kalland, K.H., Beisland, C.

Get full text

132 Metabolic Responses to VEGF Inhibition in Patient-derived Breast Cancer Xenografts by Moestue, S, Flatabo, S, Huuse, E.M, Lindholm, E.M, Engebraaten, O, Mlandsmo, G.M, Akslen, L.A, Gribbestad, I.S

Get full text

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer by Mirza, M.R., Tandaric, L., Henriksen, J.R., Mäenpää, J., Christensen, R.D., Waldstrøm, M., Lindemann, K., Roed, H., Auranen, A., Akslen, L.A., Thomsen, L.C.V., Lindberg, S.N., Madsen, K., Bjørge, L.

Get full text

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1) by Ohnstad, H.O., Blix, E.S., Akslen, L.A., Gilje, B., Raj, S.X., Skjerven, H., Borgen, E., Janssen, E.A.M., Mortensen, E., Brekke, M.B., Falk, R.S., Schlichting, E., Boge, B., Songe-Møller, S., Olsson, P., Heie, A., Mannsåker, B., Vestlid, M.A., Kursetgjerde, T., Gravdehaug, B., Suhrke, P., Sanchez, E., Bublevic, J., Røe, O.D., Geitvik, G.A., Halset, E.H., Rypdal, M.C., Langerød, A., Lømo, J., Garred, Ø., Porojnicu, A., Engebraaten, O., Geisler, J., Lyngra, M., Hansen, M.H., Søiland, H., Nakken, T., Asphaug, L., Kristensen, V., Sørlie, T., Nygård, J.F., Kiserud, C.E., Reinertsen, K.V., Russnes, H.G., Naume, B.

Get full text

103P Impact of Prosigna test on treatment decision in lymph node-negative early breast cancer: A prospective multicenter study (EMIT1) by Ohnstad, H.O., Borgen, E., Mortensen, E., Brekke, M.B., Akslen, L.A., Janssen, E.A.M., Geitvik, G.A., Rypdal, M.C., Langerød, A., Halset, E.H., Blix, E.S., Raj, S.X., Eikesdal, H.P., Gilje, B., Skjerven, H., Sclichting, E., Reinertsen, K.V., Falk, R.S., Russnes, H.E.G., Naume, B.

Get full text

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy by Aas, T., Geisler, S., Eide, G.E., Haugen, D.F., Varhaug, J.E., Bassøe, A.M., Thorsen, T., Berntsen, H., Børresen-Dale, A.-L., Akslen, L.A., Lønning, P.E.

Get full text

Aggressive Thyroid Carcinoma with Predominant Cribriform Growth Pattern by Akslen, L.A., Mæhle, B.O., Varhaug, J.E.

Get full text

CLINICOPATHOLOGICAL CHARACTERISTICS OF MELANOMAS OF THE HAND by HOVE, L.M., AKSLEN, L.A.

Get full text